4//SEC Filing
Gallotto Robert 4
Accession 0001209191-07-007005
CIK 0001340744other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 11:14 AM ET
Size
9.1 KB
Accession
0001209191-07-007005
Insider Transaction Report
Form 4
Gallotto Robert
VP, Strategic Planning
Transactions
- Sale
Common Stock
2007-02-01$18.45/sh−2,000$36,900→ 0 total - Exercise/Conversion
Common Stock
2007-02-01$3.92/sh+2,000$7,840→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-02-01−2,000→ 36,322 totalExercise: $3.92From: 2002-12-20Exp: 2012-12-19→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Gallotto on September 1, 2006.
- [F2]All of such options have a term of ten years vesting over four years, with 1/16 of the options vesting every three months.
Documents
Issuer
Altus Pharmaceuticals Inc.
CIK 0001340744
Entity typeother
Related Parties
1- filerCIK 0001350093
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 11:14 AM ET
- Size
- 9.1 KB